| Salvatore J Taliercio, MD | |
|
3927 Rucker Ave, Everett, WA 98201-4833 | |
| (425) 339-5441 | |
| (425) 259-1155 |
| Full Name | Salvatore J Taliercio |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 16 Years |
| Location | 3927 Rucker Ave, Everett, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962664763 | NPI | - | NPPES |
| 2080637 | Medicaid | WA |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Regional Medical Center Everett | Everett, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Everett Clinic Pllc | 6406752153 | 552 |
News Archive
AVANIR Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the submission of its Complete Response to the October 2006 Approvable Letter issued by the U.S. Food and Drug Administration (FDA) for Zenvia™ (dextromethorphan/quinidine) for the treatment of pseudobulbar affect (PBA). AVANIR expects the FDA to classify the response as a Class 2 resubmission, which would result in an expected review period of 180 days and potential approval of Zenvia in the fourth calendar quarter of 2010.
Palliative care-;which better aligns medical treatments with patients' goals and wishes, aggressively treats distressing symptoms, and improves care coordination, -;is associated with shorter hospital stays and lower costs, and shows its greatest effect among the sickest patients, according to a study published Monday, April 30, in JAMA Internal Medicine.
Anat Achiron, M.D., Ph.D., of Sheba Medical Center, Tel-Hashomer, Israel, and colleagues assessed the effect of IVIg treatment in patients after the first neurological event suggestive of MS and evaluated the occurrence of a second attack.
Not only does the type of flu virus affect a patient's outcome, but a new research report appearing in the Journal of Leukocyte Biology suggests that the number of viruses involved in the initial infection may be important too.
› Verified 3 days ago
| Entity Name | The Everett Clinic Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831186766 PECOS PAC ID: 6406752153 Enrollment ID: O20031211000922 |
News Archive
AVANIR Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the submission of its Complete Response to the October 2006 Approvable Letter issued by the U.S. Food and Drug Administration (FDA) for Zenvia™ (dextromethorphan/quinidine) for the treatment of pseudobulbar affect (PBA). AVANIR expects the FDA to classify the response as a Class 2 resubmission, which would result in an expected review period of 180 days and potential approval of Zenvia in the fourth calendar quarter of 2010.
Palliative care-;which better aligns medical treatments with patients' goals and wishes, aggressively treats distressing symptoms, and improves care coordination, -;is associated with shorter hospital stays and lower costs, and shows its greatest effect among the sickest patients, according to a study published Monday, April 30, in JAMA Internal Medicine.
Anat Achiron, M.D., Ph.D., of Sheba Medical Center, Tel-Hashomer, Israel, and colleagues assessed the effect of IVIg treatment in patients after the first neurological event suggestive of MS and evaluated the occurrence of a second attack.
Not only does the type of flu virus affect a patient's outcome, but a new research report appearing in the Journal of Leukocyte Biology suggests that the number of viruses involved in the initial infection may be important too.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Salvatore J Taliercio, MD Po Box 5127, Everett, WA 98206-5127 Ph: (425) 339-5441 | Salvatore J Taliercio, MD 3927 Rucker Ave, Everett, WA 98201-4833 Ph: (425) 339-5441 |
News Archive
AVANIR Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the submission of its Complete Response to the October 2006 Approvable Letter issued by the U.S. Food and Drug Administration (FDA) for Zenvia™ (dextromethorphan/quinidine) for the treatment of pseudobulbar affect (PBA). AVANIR expects the FDA to classify the response as a Class 2 resubmission, which would result in an expected review period of 180 days and potential approval of Zenvia in the fourth calendar quarter of 2010.
Palliative care-;which better aligns medical treatments with patients' goals and wishes, aggressively treats distressing symptoms, and improves care coordination, -;is associated with shorter hospital stays and lower costs, and shows its greatest effect among the sickest patients, according to a study published Monday, April 30, in JAMA Internal Medicine.
Anat Achiron, M.D., Ph.D., of Sheba Medical Center, Tel-Hashomer, Israel, and colleagues assessed the effect of IVIg treatment in patients after the first neurological event suggestive of MS and evaluated the occurrence of a second attack.
Not only does the type of flu virus affect a patient's outcome, but a new research report appearing in the Journal of Leukocyte Biology suggests that the number of viruses involved in the initial infection may be important too.
› Verified 3 days ago
Dr. Tasneem Abbas Shikary, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 12800 Bothell Everett Hwy, Everett, WA 98208 Phone: 425-316-5100 | |
James B Erhardt, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 3216 Norton Ave, Suite 102, Everett, WA 98201 Phone: 425-261-4950 | |
Mr. Matthew Nathan Ashbach, M.D Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3216 Norton Ave, Suite 102, Everett, WA 98201 Phone: 425-252-0895 Fax: 425-303-8463 | |
Dr. Fariha S. Farid, D.O. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 12800 Bothell Everett Hwy, Suite 110, Everett, WA 98208 Phone: 425-316-5100 | |
Jeffery R Adams, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3927 Rucker Ave, Everett, WA 98201 Phone: 425-339-5441 | |
Paul A Abson, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3927 Rucker Ave, Everett, WA 98201 Phone: 425-339-5441 Fax: 425-259-1154 | |
Paul Henry Bikhazi, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3927 Rucker, Everett, WA 98201 Phone: 425-339-5441 |